MACRODANTIN Drug Patent Profile
✉ Email this page to a colleague
When do Macrodantin patents expire, and when can generic versions of Macrodantin launch?
Macrodantin is a drug marketed by Almatica and is included in one NDA.
The generic ingredient in MACRODANTIN is nitrofurantoin, macrocrystalline. Twenty-eight suppliers are listed for this compound. Additional details are available on the nitrofurantoin, macrocrystalline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MACRODANTIN?
- What are the global sales for MACRODANTIN?
- What is Average Wholesale Price for MACRODANTIN?
Summary for MACRODANTIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Clinical Trials: | 6 |
Patent Applications: | 6,113 |
Drug Prices: | Drug price information for MACRODANTIN |
What excipients (inactive ingredients) are in MACRODANTIN? | MACRODANTIN excipients list |
DailyMed Link: | MACRODANTIN at DailyMed |
Recent Clinical Trials for MACRODANTIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Roswell Park Cancer Institute | Phase 4 |
National Cancer Institute (NCI) | Phase 4 |
European Commission | Phase 4 |
Pharmacology for MACRODANTIN
Drug Class | Nitrofuran Antibacterial |
US Patents and Regulatory Information for MACRODANTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almatica | MACRODANTIN | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 016620-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Almatica | MACRODANTIN | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 016620-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Almatica | MACRODANTIN | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 016620-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |